Moreover, we show that extracellular vimentin contributes to an immunosuppressive tumor environment by suppressing leukocyte adhesion molecules such as ICAM1 and inducing immune checkpoint molecules on the endothelium, thereby impairing effective leukocyte infiltration and potentially contributing to immune exhaustion. The gene discussed is VIM; the disease is neoplasm.